Translate Page To German Tranlate Page To Spanish Translate Page To French Translate Page To Italian Translate Page To Japanese Translate Page To Korean Translate Page To Portuguese Translate Page To Chinese
  Number Times Read : 6    Word Count: 901  

Arts & Entertainment
Cars and Trucks
Culture and Society
Disease & Illness
Food & Beverage
Health & Fitness
Home & Family
Internet Business
Online Shopping
Pets & Animals
Product Reviews
Recreation & Sports
Reference & Education
Self Improvement
Travel & Leisure
Womens Issues
Writing & Speaking


Nephropathic Cystinosis Treatment Market Global Market Size, Growth, Trends and 2025 Forecast Report

[Valid RSS feed]  Category Rss Feed -
By : Rohini Chaudhari    4 or more times read
Submitted 2019-06-12 11:26:36
Nephropathic cystinosis is the leading lysosomal storage disorder caused due to malfunctioning lysosomal membrane transfusion, and it assists as a prototype for a small group of lysosomal transportation disorders. The disease leads to intracellular growth of cysteine in all tissues and organs. Nephropathic cystinosis is an uncommon autosomal recessive disorder with lysosomal storing of the amino acid cysteine due to a deficiency in the membrane transfusion protein, cystinosis. Meanwhile the accessibility to cysteine-depleting medical therapy and the introduction of kidney transplants, to nephropathic cystinosis formerly fatal disease was transformed into a curable disease. Renal allografts and medical therapy targeting the basic metabolic deficit have transformed the natural history of nephropathic cystinosis so drastically that patients have extended a life expectancy past 50 years. Infantile nephropathic cystinosis is the most recurrent and severe form of cystinosis. Nephropathic cystinosis’s symptoms usually become deceptive within the second half of the first year of life. Precise symptoms can be severe or mild based on individual cases and the stage when management of nephropathic cystinosis is started.

Report Overview @

Renal Fanconi syndrome and growth failure are generally the first noticeable difficulties of nephropathic cystinosis. Although infants seem regular at birth, by the age of one they frequently fall into the third percentile for weight and height. In addition, infants suffering from nephropathic cystinosis may have poor appetite, encounter feeding difficulties, and suffer from vomiting that contribute to nutritional deficit and failure to gain weight and height at the expected rate.

The global nephropathic cystinosis treatment market is segmented on the basis of therapy, end users, and geography. Based on therapy, the market is segmented into cysteine depleting therapy, symptomatic therapy, and renal transplantation. Cysteine depleting therapy can significantly lower cysteine levels inside the cells. Cysteine depleting therapy with cysteine reduces kidney damage and improves growth in children. Cysteine can expressively postpone the need for a kidney transplant. Renal Fanconi syndrome is treated with symptomatic therapy with a high intake of electrolytes and fluids to prevent extreme decrease of body dehydration. Magnesium, sodium citrate, potassium, and sodium bicarbonate may help to keep standard electrolyte stability. Acetyl cholinesterase (ACE) inhibitors are used sometimes to curtail the progress of the renal disease. Despite prompt and early treatment, patients with intermediate cystinosis and infantile ultimately develop end stage renal disease (ESRD), that requires a kidney transplant. Primarily, a suffering individual may have to endure dialysis. Dialysis is conducted through a machine that is used to ensure certain functions of the kidney. These include retaining proper levels of necessary chemicals such as potassium, and filtering waste products from the bloodstream. Based on end user, the cystinosis treatment market is segmented into hospitals, specialty clinics, and diagnostic laboratories.

Request Brochure @

On the basis of geography, the global nephropathic cystinosis treatment market is categorized into five key regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Nephropathic cystinosis is likely to affect around 2,000 patients worldwide, comprising 800 patients in Europe and 500 patients in the U.S. Cystinosis patients have hereditary malfunctioning cysteine carrier gene which outcomes in body wide cellular toxicity occurring from the abnormal accumulation of the amino acid cysteine in the lysosomes. Europe is the dominating market followed by North America in the nephropathic cystinosis treatment market. Rising patient awareness about different treatment options and increasing demand for treatment will dominate the market in Europe. The nephropathic cystinosis treatment market is expanding due to increasing population, better treatment options, and rising demand for rapid diagnosis. The global nephropathic cystinosis treatment market is expected to expand at a healthy rate in the next few years due to lack of treatment options.

The major players operating in the global nephropathic cystinosis treatment market include Horizon Pharma Plc., Mylan N.V., Novartis AG, and Gilead. Increasing competition among key players to develop new therapy for nephropathic cystinosis treatment market will drive the market globally.

Request for TOC @

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453


Author Resource:- Nephropathic Cystinosis Treatment Market is boosted by rising patient awareness about different treatment options, increasing population, better treatment options, and rising demand for rapid diagnosis.
Article From Articles Promoter Article Directory

HTML Ready Article. Click on the "Copy" button to copy into your clipboard.

Firefox users please select/copy/paste as usual
New Members
Sign up
learn more
Affiliate Sign in
Affiliate Sign In
Nav Menu
Submit Articles
Submission Guidelines
Top Articles
Link Directory
About Us
Contact Us
Privacy Policy
RSS Feeds

Print This Article
Add To Favorites


Free Article Submission

Website Security Test